Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: A clinician survey

In acute lymphoblastic leukemia (ALL), the presence of minimal residual disease (MRD) after induction/ consolidation chemotherapy is a strong prognostic factor for subsequent relapse and mortality.